160 results on '"Goirand, Françoise"'
Search Results
2. A biological pharmacology network to secure the risk of drug–drug interaction with nirmatrelvir/ritonavir
3. [18F]FMISO PET/CT imaging of hypoxia as a non-invasive biomarker of disease progression and therapy efficacy in a preclinical model of pulmonary fibrosis: comparison with the [18F]FDG PET/CT approach
4. Pathogenesis of fibrosis in interstitial lung disease
5. Intra-individual dose escalation of abiraterone (ABI) according to its plasma exposure in patients (pts) with progressive metastatic castration-resistant prostate cancer (mRCPC): Results of the OPTIMABI trial.
6. HSPB5 Inhibition by NCI-41356 Reduces Experimental Lung Fibrosis by Blocking TGF-β1 Signaling
7. Chapitre 18 - Hypolipémiants
8. Chapitre 11 - Anti-inflammatoires stéroïdiens et non stéroïdiens
9. Chapitre 7 - Antibiotiques
10. Évaluation du niveau de preuve du suivi thérapeutique pharmacologique de l’évérolimus
11. Interaction of thiopental with esomeprazole in critically ill patients
12. Extracellular Heat Shock Proteins as Therapeutic Targets and Biomarkers in Fibrosing Interstitial Lung Diseases
13. Changes in Maternal Blood Inflammatory Markers As a Predictor Of Chorioamnionitis: A Prospective Multicenter Study
14. Dietary n-3 polyunsaturated fatty acids and endothelium dysfunction induced by lysophosphatidylcholine in Syrian hamster aorta
15. Celecoxib but not the combination of celecoxib+atorvastatin prevents the development of monocrotaline-induced pulmonary hypertension in the rat
16. The protective effect of HMG-CoA reductase inhibitors against monocrotaline-induced pulmonary hypertension in the rat might not be a class effect: comparison of pravastatin and atorvastatin
17. The HMG-CoA reductase inhibitor, pravastatin, prevents the development of monocrotaline-induced pulmonary hypertension in the rat through reduction of endothelial cell apoptosis and overexpression of eNOS
18. Association of 5-FU Therapeutic Drug Monitoring to DPD Phenotype Assessment May Reduce 5-FU Under-Exposure
19. Role of Extracellular HSP27 in pulmonary fibrosis
20. Lack of everolimus diffusion in pleural fluid during pleural progression of breast cancer: A case report
21. TRIM33 prevents pulmonary fibrosis by impairing TGF-β1 signalling
22. LSC - 2019 - TRIM33 regulates TGF-ß1 secretion and Epithelial-Mesenchymal Transition in pulmonary fibrosis
23. [18F]FMISO PET/CT imaging of hypoxia as a non-invasive biomarker of disease progression and therapy efficacy in a preclinical model of pulmonary fibrosis: comparison with the [18F]FDG PET/CT approach.
24. Activation of AMP kinase α1 subunit induces aortic vasorelaxation in mice
25. EFFECT OF DIETARY DOCOSAHEXAENOIC ACID ON THE ENDOTHELIUM-DEPENDENT VASORELAXATION IN DIABETIC RATS
26. Vitamin C Deficiency Exerts Paradoxical Cardiovascular Effects in Osteogenic Disorder Shionogi (ODS) Rats
27. Arachidonic acid relaxes human pulmonary arteries through K+ channels and nitric oxide pathways
28. 5-fluorouracil therapeutic drug monitoring Update and recommendations of the STP-PT group of the SFPT and the GPCO-Unicancer
29. TRIM33 regulates TGF-ß1 secretion and Epithelial-Mesenchymal Transition in pulmonary fibrosis
30. Role of extracellular HSP27 in idiopathic pulmonary fibrosis (IPF)
31. How can we best monitor 5-FU administration to maximize benefit to risk ratio?
32. TIF1? has a protective role in pulmonary fibrosis
33. Suivi thérapeutique pharmacologique du 5-fluorouracile : mise au point et recommandations du groupe STP-PT de la SFPT et du GPCO-Unicancer
34. Effects of phosphodiesterase inhibitors on hypoxic pulmonary vasoconstriction. Influence of K + channels and nitric oxide
35. P105 Deglycosylated bleomycin has the antitumor activity of bleomycin without pulmonary toxicity
36. 5-FU therapeutic drug monitoring as a valuable option to reduce toxicity in patients with gastrointestinal cancer
37. Liste des auteurs
38. Pleural inhibition of the caspase-1/IL-1β pathway diminishes profibrotic lung toxicity of bleomycin
39. Pharmacokinetics, pharmacodynamics and clinical efficacy of omalizumab for the treatment of asthma
40. LSC Abstract – Pleural inflammation is essential in bleomycin-induced lung toxicity
41. Lack of everolimus diffusion in pleural fluid during pleural progression of breast cancer: A case report.
42. Deglycosylated bleomycin has the antitumor activity of bleomycin without pulmonary toxicity
43. Pharmacologie et thérapeutiques : Unité d'enseignement 2.11
44. [Level of evidence for therapeutic drug monitoring of everolimus]
45. Changes in Maternal Blood Inflammatory Markers As a Predictor Of Chorioamnionitis: A Prospective Multicenter Study
46. ADRB3 adrenergic receptor is a key regulator of human myometrial apoptosis and inflammation during chorioamnionitis
47. Activation of AMP kinase alpha1 subunit induces aortic vasorelaxation in mice
48. Stimulation of the ADRB3 adrenergic receptor induces relaxation of human placental arteries: influence of preeclampsia
49. Pharmacokinetic evaluation of esomeprazole for the treatment of gastroesophageal reflux disease
50. Role of potassium channels and nitric oxide in the relaxant effects elicited by β-adrenoceptor agonists on hypoxic vasoconstriction in the isolated perfused lung of the rat
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.